Close Menu

Eli Lilly

NEW YORK (GenomeWeb News) – Molecular diagnostics firm PrimeraDx today announced a deal with Eli Lilly to develop diagnostics in support of the drug firm's therapeutic development programs.

NEW YORK (GenomeWeb News) – A pair of studies in the early, online version of Nature Genetics are highlighting the types of genetic mutations that underlie the liver cancer hepatocellular carcinoma, including forms of the disease related to hepatitis B and hepatitis C virus infection.

NEW YORK (GenomeWeb News) – Launching what will be the maiden initiative for the months-old National Center for Advancing Translational Sciences, National Institutes of Health Director Francis Collins today unveiled a program that will support researchers using biomarker-based studies and other a

After a survey of UK oncologists revealed that access hurdles and high costs associated with biomarker testing are limiting their ability to prescribe personalized treatments, Merck Serono has issued a "call to action" for the government and pharmaceutical industry to work togeth

Eli Lilly said last week that it received a complete response letter from the US Food and Drug Administration declining its application to market Erbitux as a first-line treatment for non-small cell lung cancer.

The Asia Cancer Research Group and BGI plan to collaborate on a project to genomically characterize lung and liver tumors, BGI said last week.

This story originally ran on Dec. 22.
By Adam Bonislawski

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.